除顫器全球市場展望
市場調查報告書
商品編碼
1214696

除顫器全球市場展望

Defibrillator: Global Market Outlook

出版日期: | 出版商: BCC Research | 英文 78 Pages | 訂單完成後即時交付

價格

由於生活方式的改變導致心血管疾病 (CVD) 患病率上升正在推動除顫器市場。

此外,皮下植入式心律轉復除顫器 (S-ICD) 和心臟再同步治療除顫器 (CRT-D) 的開發也有望在預測期內推動市場增長。

本報告對全球除顫器市場進行研究分析,提供市場動態、市場分析、公司概況等系統信息。

內容

第一章市場展望

  • 市場概況

第 2 章總結和要點

第 3 章市場概述

  • 除顫器
  • 植入式心律轉復除顫器 (ICD)
    • 靜脈或傳統除顫器
    • 皮下除顫器
    • 心臟再同步化治療 - 除顫器
  • 體外除顫器
    • 手動體外除顫器
    • 自動體外除顫器 (AED)
    • 可穿戴除顫器 (WCD)
  • 市場驅動因素
    • 心髒病患病率增加
    • 除顫器的技術進步
    • 提高認識和政府舉措
  • 市場壁壘
    • 植入式和自動體外除顫器的技術問題
    • 缺乏培訓和意識
  • 市場機會
    • 新興市場對除顫器的需求不斷增長
    • COVID-19 大流行的影響

第 4 章市場細分:按類型

  • 除顫器市場:按類型分類
    • 市場概覽
    • 市場收入
    • 植入式除顫器
    • 體外除顫器

第 5 章市場細分:按最終用戶

  • 概覽
  • 醫院、診所、心臟中心
  • 公共訪問和院前
  • 家庭護理

第 6 章市場細分:按地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 世界其他地區

第七章競爭格局

  • 合併、收購和合作
    • 除顫器市場的近期趨勢
    • 除顫器市場份額
    • 2019 年、2020 年和 2021 年上市前 AED 獲得 FDA 批准
    • 最近的產品召回

第八章公司簡介

  • ABBOTT LABORATORIES
  • ASAHI KASEI CORP.
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • DEFIBTECH LLC
  • LIVANOVA
  • MEDIANA
  • MEDTRONIC PLC
  • NIHON KOHDEN CORP.
  • PHILIPS MEDICAL CORP.
  • STRYKER CORP.

第 9 章項目範圍和研究方法

  • 報告範圍
  • 調查方法
  • 分析師簡歷
  • BCC 自定義調查
  • 相關 BCC 研究報告
Product Code: MDS082A

Highlights:

This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and rising opportunities in the developed and developing world.

Report Scope:

The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase. During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.

This report provides a brief exposure to the defibrillators global market. This report highlights the current and future market potential for this medical equipment and offers a brief analysis of the market's drivers, challenges, and opportunities. Revenues are broken down by region, type, and end user. For market estimates, data has been provided for 2019, 2020 and 2021 (as the base year), projections for 2022, and a forecast for 2027. The report also covers the market share for major market players. It includes the company profiles of the major players, with brief information about their business segments, financials, product portfolios, and recent developments. The report also provides an analysis of the impact of the COvID-19 pandemic on this market.

This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world.

Report Includes:

  • A brief general outlook of the global market for defibrillators
  • Analysis of current and future market potential and discussion on the market drivers, challenges, and opportunities
  • Analyses of global market trends with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Segmentation of the defibrillators market by type, end use and region
  • Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants

Table of Contents

Chapter 1 Market Outlook

  • 1.1 Market Snapshot

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • 3.1 Defibrillators
  • 3.2 Implantable Cardioverter Defibrillators (ICDs)
    • 3.2.1 Transvenous or Traditional ICDs
    • 3.2.2 Subcutaneous ICDs
    • 3.2.3 Cardiac Resynchronization Therapy-Defibrillator
  • 3.3 External Defibrillators
    • 3.3.1 Manual External Defibrillators
    • 3.3.2 Automated External Defibrillators (AEDs)
    • 3.3.3 Wearable Cardioverter Defibrillators (WCDs)
  • 3.4 Market Drivers
    • 3.4.1 Increasing Prevalence of the Cardiac Disorders
    • 3.4.2 Technological Advancements in Defibrillators
    • 3.4.3 Growing Awareness and Government Initiatives
  • 3.5 Market Barriers
    • 3.5.1 Technical Issues in Implantable and Automated External Defibrillators
    • 3.5.2 Lack of Training and Awareness
  • 3.6 Market Opportunities
    • 3.6.1 Rise in Demand for Defibrillators in Emerging Markets
    • 3.6.2 Impact of COVID-19 Pandemic

Chapter 4 Market Breakdown by Type

  • 4.1 Market by Type of Defibrillator
    • 4.1.1 Market Overview
    • 4.1.2 Market Revenue
    • 4.1.3 Implantable Cardioverter Defibrillators
    • 4.1.4 External Defibrillators

Chapter 5 Market Breakdown by End User

  • 5.1 Overview
  • 5.2 Hospitals, Clinics and Cardiac Centers
  • 5.3 Public Access and Pre-hospital
  • 5.4 Home Care

Chapter 6 Market Breakdown by Region

  • 6.1 Introduction
  • 6.2 North America
  • 6.3 Europe
  • 6.4 Asia-Pacific
  • 6.5 Rest of the World

Chapter 7 Competitive Landscape

  • 7.1 Mergers, Acquisitions, and Collaborations
    • 7.1.1 Recent Developments in the Market for Defibrillators
    • 7.1.2 Defibrillator Market Shares
    • 7.1.3 FDA approvals for Premarket AEDs in 2019, 2020 and 2021
    • 7.1.4 Recent Product Recalls

Chapter 8 Company Profiles

  • ABBOTT LABORATORIES
  • ASAHI KASEI CORP.
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • DEFIBTECH LLC
  • LIVANOVA
  • MEDIANA
  • MEDTRONIC PLC
  • NIHON KOHDEN CORP.
  • PHILIPS MEDICAL CORP.
  • STRYKER CORP.

Chapter 9 Project Scope and Methodology

  • 9.1 Scope of Report
  • 9.2 Methodology
  • 9.3 Analyst's Credentials
  • 9.4 BCC Custom Research
  • 9.5 Related BCC Research Reports

List of Tables

  • Summary Table : Global Market for Defibrillators, by Type, Through 2027
  • Table 1 : Global Market for Defibrillators, by Type, Through 2027
  • Table 2 : Global Market for Implantable Cardioverter Defibrillators, by Region, Through 2027
  • Table 3 : Global Market for Implantable Cardioverter Defibrillators, by Type, Through 2027
  • Table 4 : Global Market for External Defibrillators, by Region, Through 2027
  • Table 5 : Global Market for External Defibrillators, by Type, Through 2027
  • Table 6 : Global Market for Defibrillators, by End User, Through 2027
  • Table 7 : Global Market for Defibrillators in Hospitals, Clinics, and Cardiac Centers, by Region Through 2027
  • Table 8 : Global Market for Public Access and Pre-hospital Defibrillators, by Region, Through 2027
  • Table 9 : Global Market for Home Care Defibrillators,, by Region, Through 2027
  • Table 10 : Global Market for Defibrillators, by Region, Through 2027
  • Table 11 : North American Market for Defibrillators, by Type, Through 2027
  • Table 12 : European Market for Defibrillators, by Type, 2019-2027
  • Table 13 : Asia-Pacific Market for Defibrillators, by Type, 2019-2027
  • Table 14 : Rest of the World Market for Defibrillators, by Type, 2019-2027
  • Table 15 : Mergers and Acquisitions in the Defibrillator Market, 2019-2022
  • Table 16 : FDA Premarket Approvals for Defibrillators, 2019-2022
  • Table 17 : Recent Product Recalls, 2019-2022
  • Table 18 : Abbott: Financial Performance, 2019-2021
  • Table 19 : Asahi Kasei Corp.: Business Segments
  • Table 20 : Asahi Kasei Corp.: Financial Performance, 2019-2021
  • Table 21 : Biotronik: Business Segments
  • Table 22 : Boston Scientific Corp.: Business Segments
  • Table 23 : Boston Scientific Corp.: Financial Performance, 2019-2021
  • Table 24 : LivaNova plc: Business Segments
  • Table 25 : LivaNova plc: Financial Performance, 2019-2021
  • Table 26 : Mediana: Business Segments
  • Table 27 : Medtronic plc: Business Segments
  • Table 28 : Medtronic plc: Financial Performance, 2019-2021
  • Table 29 : Nihon Kohden: Business Segments
  • Table 30 : Nihon Kohden: Financial Performance, 2019-2021
  • Table 31 : Philips Medical Corp.: Business Segments
  • Table 32 : Philips Medical Corp.: Financial Performance, 2019-2021
  • Table 33 : Stryker Corp.: Business Segments
  • Table 34 : Stryker Corp.: Financial Performance, 2019-2021

List of Figures

  • Summary Figure : Global Market for Defibrillators, by Type, 2019-2027
  • Figure 1 : Global Market for Defibrillators, by Type, 2019-2027
  • Figure 2 : Global Market Share of Defibrillators, by Type, 2021
  • Figure 3 : Global Market for Implantable Cardioverter Defibrillators, by Region, 2019-2027
  • Figure 4 : Global Market for Implantable Cardioverter Defibrillators, by Type, 2019-2027
  • Figure 5 : Global Market for External Defibrillators, by Region, 2019-2027
  • Figure 6 : Global Market for External Defibrillators, by Type, 2019-2027
  • Figure 7 : Global Market for Defibrillators, by End User, 2019-2027
  • Figure 8 : Global Market for Defibrillators in Hospital, Clinics, and Cardiac Centers, by Region, 2019-2027
  • Figure 9 : Global Market for Public Access and Pre-hospital Defibrillators, by Region, 2019-2027
  • Figure 10 : Global Market for Home Care Defibrillators, by Region, 2019-2027
  • Figure 11 : Global Market for Defibrillators, by Region, 2019-2027
  • Figure 12 : Global Market Share of Defibrillators, by Region, 2021
  • Figure 13 : North American Market for Defibrillators, by Type, 2019-2027
  • Figure 14 : European Market for Defibrillators, by Type, 2019-2027
  • Figure 15 : Asia-Pacific Market for Defibrillators, by Type, 2019-2027
  • Figure 16 : Rest of the World Market for Defibrillators, by Type, 2019-2027
  • Figure 17 : Global Market Share of Defibrillators, by Key Manufacturer, 2021
  • Figure 18 : Abbott: Annual Revenue, 2019-2021
  • Figure 19 : Abbott: Net Sales, by Business Segment, 2021
  • Figure 20 : Abbott: Net Sales, by Region, 2021
  • Figure 21 : Asahi Kasei Corp.: Annual Revenue, 2019-2021
  • Figure 22 : Asahi Kasei Corp.: Net Sales, by Business Segment, 2021
  • Figure 23 : Asahi Kasei Corp.: Net Sales, by Region, 2021
  • Figure 24 : Boston Scientific Corp.: Annual Revenue, 2019-2021
  • Figure 25 : Boston Scientific Corp.: Net Sales, by Business Segment, 2021
  • Figure 26 : Boston Scientific Corp.: Net Sales, by Region, 2021
  • Figure 27 : LivaNova plc: Annual Revenue, 2019-2021
  • Figure 28 : LivaNova plc: Net Sales, by Business Segment, 2021
  • Figure 29 : LivaNova plc: Net Sales, by Region, 2021
  • Figure 30 : Medtronic plc: Annual Revenue, 2019-2021
  • Figure 31 : Medtronic plc: Net Sales, by Business Segment, 2021
  • Figure 32 : Medtronic plc: Net Sales, by Region, 2021
  • Figure 33 : Nihon Kohden: Annual Revenue, 2019-2021
  • Figure 34 : Nihon Kohden: Net Sales, by Business Segment, 2021
  • Figure 35 : Nihon Kohden: Total Revenue, by Region, 2021
  • Figure 36 : Philips Medical Corp.: Annual Revenue, 2019-2021
  • Figure 37 : Philips Medical Corp.: Net Sales, by Business Segment, 2021
  • Figure 38 : Philips Medical Corp.: Net Sales, by Region, 2021
  • Figure 39 : Stryker Corp.: Annual Revenue, 2019-2021
  • Figure 40 : Stryker Corp.: Net Sales, by Business Segment, 2021
  • Figure 41 : Stryker Corp.: Net Sales, by Region, 2021